Patients file Levaquin lawsuit against drug maker
Five patients who were given the powerful antibiotic Levaquin filed a lawsuit against the drugmaker, Janssen Pharmaceuticals and its parent company Johnson & Johnson. The patients are seeking $800 million in the Levaquin lawsuit, including more than $120 million to compensate for medical bills and loss of work due to Levaquin side effects.
The Levaquin lawsuit alleges that J & J and Janssen misled patients and doctors, downplaying the risks of side effects associated with the drug. Patients have complained of severe complications from Levaquin, such as ruptured tendons, nervous system damage, paralysis, peripheral neuropathy, weakness and fatigue, vision problems and skin problems.
More than 80,000 Levaquin complaints have been filed to the U.S. Food and Drug Administration, including 5,000 cases that involved death. The drug belongs to a class known as fluoroquinolones (FQLs), which also include the antibiotic Avelox. FQLs are among the most-prescribed drugs by primary care doctors.